Terms: = Ovarian cancer AND IKBKB, O14920, 3551, ENSG00000104365
5 results:
1. KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma.
Saglam O; Tang Z; Tang G; Medeiros LJ; Toruner GA
PLoS One; 2020; 15(9):e0238477. PubMed ID: 32877461
[TBL] [Abstract] [Full Text] [Related]
2. Identification of key genes and pathways associated with topotecan treatment using multiple bioinformatics tools.
Kang YM; Lan A; Huang YH; Hsu KM; Chao Y; Lan KL
J Chin Med Assoc; 2020 May; 83(5):446-453. PubMed ID: 32243271
[TBL] [Abstract] [Full Text] [Related]
3. Prospective Study Evaluating Changes in Bone Quality in Premenopausal Women With Breast cancer Undergoing Adjuvant Chemotherapy.
Hopson MB; Onishi M; Awad D; Buono D; Maurer M; Crew KD; Shane E; Hershman DL; Kalinsky K
Clin Breast Cancer; 2020 Jun; 20(3):e327-e333. PubMed ID: 31926840
[TBL] [Abstract] [Full Text] [Related]
4. Paclitaxel Sensitivity of ovarian cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.
Yang H; Mao W; Rodriguez-Aguayo C; Mangala LS; Bartholomeusz G; Iles LR; Jennings NB; Ahmed AA; Sood AK; Lopez-Berestein G; Lu Z; Bast RC
Clin Cancer Res; 2018 Oct; 24(20):5072-5084. PubMed ID: 30084832
[No Abstract] [Full Text] [Related]
5. The vascular impact of uterine artery embolization: prospective sonographic assessment of ovarian arterial circulation.
Ryu RK; Chrisman HB; Omary RA; Miljkovic S; Nemcek AA; Saker MB; Resnick S; Carr J; Vogelzang RL
J Vasc Interv Radiol; 2001 Sep; 12(9):1071-4. PubMed ID: 11535770
[TBL] [Abstract] [Full Text] [Related]
